Cannabis is the most commonly abused drug in the world. In Egypt, the Anti Narcotic General Administration showed that the narcotics problem costs the Egyptian economy approximately 800 million dollars annually. LD50, lethal dose that kills 50% of the treated animals, of the bango was determined and then selected groups of rats were given tenth of LD50 for 90 days. The histopathological effects were determined. All the studied organs were affected markedly in the form of shrunken cells in brain. The liver cells were affected in the form of rarefaction of the cytoplasm, kidneys were with severe congestion. The testicles were with disruption of the spermatogenic cells from the membrane.
Guxens M., Nebot M., Ariza C., Ochoa D.Factors associated with the onset of cannabis use: a systematic review of cohort studies. Gac Saint2007; 21: 252-260.
2.
Alvarez FJ, Fierro I., Del Río MCCannabis and driving: results from a general population survey. J Forensic Sci Int2007; 170: 111-116.
3.
Interpol Drug Substances Directorate.Drug abuse. www.Interpol.int/public/Drugs/cannabis.asp (2006, accessed May 2006).
4.
El Akabawi ASDrug abuse in the Arab world: a country profile of Egypt. World Psych Association Series2001 ; 3: 143-15.
5.
Abdel Gawad S.Facets of drug abuse in Egypt: An overview. E-journal of the International Society of Addiction. www.ucalgary.ca/uafc/department/UP/journals.com (accessed April 2006).
6.
Frank M., Rosenthal E.Cannabis and ancient history. In: Frank M., Wiliams O, and Kallan L.Marijuana Grower’s Guide. 2nd edition. Chapter 1. Framington hills 1978, p. 3-10.
7.
Macphee D.Effects of marijuana on cell nuclei: a review of the literature relating to the genotoxicity of cannabis. In: Kalant H , Corrigal W, Hall W, Smart R (eds.). The Health Effects of Cannabis. 1stedn. Chap. 8. Toronto Center for Addiction and Mental Health. 1999, p.293-30.
8.
Huestis M.Cannabis effects on human behavior and performance. J Forensic Sci Rev2002; 14: 1-25.
9.
Zimmer L., and Morgan J.Route of administration of cannabis. In: Zimmer L., and Morgan J.Marijuana Facts: a review of scientific evidence. 2nd edition. Chapter 3. New York: Lindesmith Center, 1997, p. 90-97.
10.
Elwan O., Hassan A., Nasser M., et al. Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking. J Neurological Sci1997; 148: 79-86.
11.
Hezode C., Thoraval F., Nguyen S., et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology2005; 42: 63-71.
12.
Lambrecht N.Marijuana smoking associated with kidney damage . Publication of Drug Watch Oregan1996; 3: 1-3.
13.
Sigman M., Howards S.Male infertility. In: Walsh P (ed.) Campbell’s urology. 7th ed. Chap. 10. Philadelphia: Saunders, 1998, p.1287-1300.
14.
Fadda P., Robinson L., Fratta W., Pertwee R., Riedel G.Differential effects of THC or CBD rich cannabis extracts on working memory in rats. Neuropharmacology2004; 47: 1170-1179.
15.
Singh M., McGregor I., Mallet P.Perinatal exposure to Δ9 tetrahydrocannabinol alters heroin induced place conditioning and Immunoreactivity. Neuropsychopharmacology2006; 31: 58-69.
16.
Bianchi V., Donazelli G.Rapid reversed phase high performance liquid chromatographic method for the assay of urinary 11- nor Δ9 tetrahydrocannabinol -9 carboxylic acid and confirmation of use of cannabis derivatives. J Chromatogr B1996; 675: 162-167.
17.
Hammond ACAnimal well-being in pharmacology and toxicology research. J Anim Sci. 1994; 72: 523-527.
18.
Gad S., Weil C.Statistics for toxicologists. In Hayes A (ed.) Principles and methods of toxicology. 2nd ed. Chap. 15. New York: Raven Press, 1989, p.435-479.
19.
20.
Shivprakash C.A computer program for calculation of LD50 . Indian Journal of Pharmacology1995; 27: 253-257.
21.
Chopra S., Soni R., Chopra A.A computer program for determination of LD50 using Dbase/Foxpro. Indian Journal of Pharmacology2000; 32: 390-391.
22.
Shiojiri N.Analysis of differentiation of hepatocytes and bile duct cells in developing mouse liver by albumin immunofluorescence. Develop Growth Differ1984; 26: 555-561.
23.
Iversen L.Cannabis and the brain. Brain2003; 126: 1252-1270.
24.
Downer EJ, Gowran A., Murphy AC, Campbell VAThe tumor suppressor protein, p53, is involved in the activation of the apoptotic cascade by Delta9-tetrahydrocannabinol in cultured cortical neurons. Eur J Pharmacol2007; 564: p.57-65.
25.
Sánchez C., Galve-Roperh I., Canova C., Brachet P., Guzmán M.Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett1998; 436:p.6-10.
26.
Zimmerman H.Vulnerability of the liver to toxic agents. In: Hepatotoxicity: the adverse effects of drugs. 2nd ed. Chap. 3. Philadelphia: Lippicott Williams and Wilkins, 1995, p.41-81.
27.
Barini P., Cardoso R., Bicalho S.Possible hepatotoxicity of chronic marijuana usage. Soo Paulo Med J1995; 122; p.110-116.
28.
Atici S., Cinel I., Cinel L., Doruk N., Eskandare G., Oral U.Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci2005; 30: p.254-252.
29.
Athanasiou A., Clarke A., Turner A., et al. Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun2007; 364: 131-137.
30.
Gye M., Kang H., Kang H.Expression of cannabinoid receptor in mouse testis. Arch Androl2005; 51: 147-155.
31.
Pardo G., Legua V., Remohi J., Bonilla musoles F. Review and uptake: marijuana and reproduction. Acta Ginecol1985; 42: 420-429.
32.
Rubino T., Vigano D., Realini N., et al. Chronic delta 9 tetrahydrocannabinol during adolesece provokes sex dependent changes in the emotional profile in adult rats. Behav Biochem Correlates Neuropsychopharmacology2008; 33: 2760-2771.
